A single nucleotide polymorphism (rs8570) in the 3’UTR of the RRAS2 mRNA has been identified in CLL patients, linking higher expression of RRAS2 with more aggressive disease. Here, RRAS2 is linked to B-cell chronic lymphocytic leukemia.